Stryker Secures FDA Nod for Apple Vision Pro Surgical App in Hip Arthroscopy
Event summary
- Stryker completed the first surgical procedure using SportSuite Vision on Apple Vision Pro at Duke Health on September 1, 2026.
- SportSuite Vision received FDA De Novo authorization on July 17, 2026, marking the first FDA-authorized surgical application for Apple Vision Pro.
- The technology integrates arthroscopic video, HipCheck, HipMap, and CT imaging into a spatial computing environment for surgeons.
- Stryker aims to streamline operating room workflows by reducing reliance on traditional monitors.
The big picture
Stryker's FDA authorization for SportSuite Vision on Apple Vision Pro represents a significant step in integrating spatial computing into surgical workflows. This move aligns with broader industry trends toward digital transformation in healthcare, where technology aims to enhance precision and efficiency in operating rooms. The success of this application could set a precedent for future FDA authorizations of spatial computing tools in medical procedures.
What we're watching
- Adoption Pace
- The pace at which other medical centers adopt SportSuite Vision will indicate its market potential.
- Regulatory Expansion
- Whether the FDA authorization will extend to other surgical applications beyond hip arthroscopy.
- Competitive Response
- How competitors in medical technology respond to Stryker's spatial computing integration in surgery.
Related topics